Orsini, a leader in rare disease pharmacy solutions, has been selected by Neurotech Pharmaceuticals, Inc., as the exclusive specialty pharmacy partner for ENCELTOtm (revakinagene taroretcel-lwey), an ...

Orsini, a leader in rare disease pharmacy solutions, has been selected by Neurotech Pharmaceuticals, Inc., as the exclusive ...

Charles C. Wykoff, MD, PhD, Retinal Consultants of Texas, spoke to the current state of research on revakinagene taroretcel ...

The approval of revakinagene taroretcel (Encelto; Neurotech) addresses a significant unmet need for patients with macular ...

Mirian's condition, Ataxia-Telangiectasia, impacts her nervous and immune systems, creating mobility and ongoing health challenges. Her family has set up a GoFundMe campaign to raise $15,000 for a ...

Horbelt Intermediate School early because she was ill. Mirian was born with Ataxia-Telangiectasia (A-T), a disorder that impacts the nervous system and immune system. This past fall, she began using ...

Department of Radiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China Hereditary hemorrhagic telangiectasia (HHT) is a rare autosomal dominant disorder.

The Food and Drug Administration (FDA) has approved Encelto ™ (revakinagene taroretcel-lwey) for the treatment of macular telangiectasia type 2 (MacTel). MacTel is a rare, progressive eye disease that ...